Amahitamo ya Metastatike Amahitamo yo kuvura Kanseri

Kanseri ya Statatike ya prostate ni kanseri ya prostate yakwirakwiriye hejuru ya glande ya prostate mubindi bice byumubiri. Amahitamo yo kuvura aratandukanye bitewe nurwego rwakwirakwira, ubuvuzi bwabanje, nubuzima bwumurwayi muri rusange. Ibitabo rusange birimo imivugo, chimiotherapie, impfumu, nubuvuzi bwimirasire. Guhangana bishya nka radiophasicaceuticace na parp kubuza nabyo birakoreshwa. Shandong Baofa Kanseri Ikigo cyubushakashatsi cyeguriwe gutanga imitekerereze yubushakashatsi nuburyo bwo kuvura no kunoza ibizasohozi Kanseri ya Metastatike Iyo ikwirakwira muri glande ya prostate ahantu, cyane cyane amagufwa, lymph node, umwijima, n'ibihaha. Ningenzi gusobanukirwa icyiciro nicyiciro cya kanseri kugirango umenye inzira nziza y'ibikorwa. Gusuzuma mubisanzwe bikubiyemo ibizamini byamatekengo nkigitange byamagufwa, ct scan, na misi, hamwe na kanseri ya kanseri cyangwa lymptate, hanyuma ushireho ibibyimba bishya mu nzego zituruka. Ihinduka ryimiterere nibintu bifitanye isano na microenvinonment birashobora gutanga umusanzu kuriyi nzira. The Gleason score and the presence of specific biomarkers also play a vital role in predicting the risk of metastasis.Standard Treatment Options for Metastatic Prostate CancerSeveral established treatment options are available for managing Kanseri ya Metastatike. Ibi bikunze gukoreshwa mu guhuza cyangwa bikurikiranye kugirango birusheho gukora neza.Ibikoresho byo kuvura (ADT) bizwi kandi bizwi cyane ku buvuzi bwa Androgen. Ibi birashobora kugerwaho binyuze mumodoka yo kubaga (Orchiectomy) cyangwa Ubuvuzi bwubuvuzi ukoresheje LHRH abagome cyangwa antagoniste. Ingaruka zisanzwe zirimo urumuri rushyushye, gutakaza libido, dysile idahwitse, numunaniro. Adt akenshi ni umurongo wambere Kanseri ya Metastatike.Abashaka. Bikoreshwa kenshi mugihe ubuvuzi bwa hormone butagikora neza (kanseri yinyanja irwanya - CRPC). Imiti isanzwe ya chime isanzwe ikoreshwa muri kanseri ya prostate harimo Docetaxel na Cabotaxel. Ingaruka mbi zirashobora kubamo isesemi, kuruka, guta umusatsi, umunaniro, no kongera ibyago byo kwandura. Shandong Baofa Kanseri Ikigo cyubushakashatsi ashimangira ingaruka zuruhande rwiyongera kugirango utezimbere ubuzima bwiza.Umuvumo wo kuvura imivugo ikoresha imivugo cyangwa ibice byo kwica kanseri. Irashobora gukoreshwa mugufata glande ya prostate ubwayo (kuvuza imivugo yo hanze cyangwa brachytherapy) cyangwa kwitiranya imbuga zamagufwa (imikoreshereze yimikorere ya Braam). Gutanga imirasire birashobora gufasha kugabanya ububabare no kuzamura imibereho. Ingaruka mbi ziterwa n'akarere kavuwe ariko zishobora kuba zirimo umunaniro, uruhu, n'amarambe.surgessurkurby, nka prostatectomy, ntabwo ikoreshwa na Kanseri ya Metastatike. Ariko, birashobora gusuzumwa mubihe byihariye, nko gukuraho ikibyimba cyibanze cyo kugabanya ibimenyetso cyangwa guhuza ubundi buvuzi. Gukuraho kubaga ibikomere bya metastatike ntibikunze gukorwa.Nebwe no kuvugwa no kuvurwa muri shyashya Amahitamo ya Metastatike Amahitamo yo kuvura Kanseri Ese guhora ihura, itanga ibyiringiro kubisubizo byanonosoye hamwe nubuzima bwiza. Hano harimwe murwego rushya: RadipomaceticationsradioMacemiomacekacemaces nibiyobyabwenge bitanga imirasire mu buryo butaziguye kanseri. Radium-223 dichloride (xofloride (xofpid) ni radioMhaceutical yakoreshwaga mu kuvura amagufwa ku bantu barwaye crpc. Luthetium-177 PSMA-617 niyindi RadioPhauticace itegura prostate-yihariye (PSMA), poroteyine iboneka hejuru ya selile kanseri ya prostate. Ingaruka mbi zirashobora kubamo guhagarika amagufwa hamwe numunaniro.imMunotherapimMunotherapy Harsees Imbaraga zumubiri wa sisitemu yo kurwanya kanseri. Siplubuleucel-t (proneshe) nigikoresho cya impfubyi cyemewe kuri asmpmotictic cyangwa ibimenyetso bikemuse. Harimo gukusanya ingirabuzimafatizo z'umurwayi, ubahindura kumenya selile kanseri ya prostate, hanyuma ubareke mu murwayi. Pembezimab, intangaliki zabashinzwe, irashobora kuba amahitamo abarwayi mu ihinduka ryihariye rya genetike cyangwa muri MSI-H.PARP ibiyobyabwenge bihagarika imiyoboro ya parp, bigira uruhare mu gusana kwa ADN. Iyi miti irashobora kuba ingirakamaro mubarwayi bafite ihinduka rya genetike, nka BRCA1 / 2 MUGITARI. Olaparib na Rucaparib ni ababuza Parp bemerewe kuvura CRPC. Ingaruka zisanzwe zirimo kubura amaraso, umunaniro, na Naesea. Shandong Baofa kanseri Ikigo cyubushakashatsi kigira uruhare rugaragara mubushakashatsi bukoresha uburyo bwo gukoresha ibibuza PARP mu guhuza nabandi bavuzi. Urashobora kwiga byinshi kubyerekeye ababuza kuri Urubuga rwigihugu rwa kanseri.Ibikoresho byo kuvura imivugo bikoresha ibiyobyabwenge byibasiye molekile zimwe na zimwe zagize uruhare mu mikurire ya kanseri no kubaho. Ingero zirimo ibiyobyabwenge bibuza inzira zimenyetso nka Pi3k / Akt / Mtor inzira. Ubu buvuzi busanzwe bukoreshwa mubigeragezo kandi biracyakorwaho iperereza kubikorwa byabo byo kuvura Kanseri ya Metastatike. Ingamba zo kwita ku gihe zishingiye ku ndwara no guteza imbere ibyago guhitamo kwivuza biterwa n'ibintu byinshi, harimo n'urwego rw'indwara, ubuzima rusange bw'umurwayi, ndetse n'ubuvuzi bwabanje. Imbonerahamwe ikurikira ivuga muri make icyerekezo rusange cyo kuvura: Icyiciro / Ibyago bisanzwe byo kuvura imisemburo-yoroheje ya Metastate. Kurwanya Stativem Prosate kanseri (CRPC), na werogen reseptor ibirabujije, radiophaceuticals, radiophaceuticals, imyumuha, ababuza (niba bishoboka), cyangwa ibigeragezo. Amagufwa agereranya imivugo, radiophaticaceuticals, bisphosshonate cyangwa denosumab (abashinzwe amagufwa). Ibigeragezo by'amavuriro n'ibihe bizaza ibigeragezo bigezweho ni ngombwa mugutezimbere imiti mishya kandi iteye imbere kuri Kanseri ya Metastatike. Abarwayi barashobora gutekereza kugeragezwa ku magare kugira ngo babone gukata-inkombe kandi bagatanga umusanzu mu bushakashatsi bw'ubuvuzi. Ubushakashatsi bukomeje bwibanze ku guteza imbere imiti ifatika, imbura, no guhuza imikorere. Shandong Baofa kanseri Ikigo cy'ubushakashatsi kigira uruhare runini mu gukora ibigeragezo by'amavuriro no guteza imbere umurima wa kanseri ya prostate. Urashobora kuvugana Shandong Baofa Kanseri Ikigo cyubushakashatsi Kumakuru ku bigeragezo by'ubuvuzi no guhitamo kwivuza.living hamwe na metastate ya metastate kanseri hamwe Kanseri ya Metastatike irashobora kwerekana ibibazo bikomeye. Gucunga Ibimenyetso, Guhangana n'ingaruka mbi, no gukomeza ubuzima bwiza ni ibintu byingenzi byo kwitaho. Amatsinda ashyigikira, ubujyanama, hamwe na serivisi zita kuri palliative barashobora gutanga ubufasha bwingirakamaro. Gushyikirana kumugaragaro nabatanga ubuzima ni ngombwa mugukora ibyemezo byuzuye no kwakira neza ubufasha bushoboka .Acogore Kanseri ya Metastatike ni ibintu bikomeye, uburyo bwinshi bwo kuvura burahari kugirango bufashe gucunga indwara, kuzamura imibereho, no kubaho kubaho. Gukomeza kumenyeshwa iterambere rigezweho mu kuvura no gukorana cyane nitsinda ryinshi ryinzobere mu buvuzi ni ngombwa mu gufata ibyemezo kumenyeshwa no kwakira neza. Shandong Baofa kanseri Ikigo cyubushakashatsi cyiyemeje gutanga ubuvuzi bwuzuye no gutera imbere murwego rwa prostate yubushakashatsi no kuvura.